Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05615844 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
NotablePrimary completion date: Mar 31, 2025 to Mar 31, 2027
Study sites: 18 to 20
Study completion date: Oct 1, 2025 to Oct 1, 2027
v14
MinorEligibility criteria expanded, about 10 wordsv13
MinorStudy sites: 17 to 18v12
MinorStudy sites: 16 to 17v11
MinorStudy sites: 14 to 16v10
MinorStudy sites: 13 to 14v9
MinorStudy sites: 12 to 13v8
MinorStudy sites: 1 to 12v7
NotableTrial status: Not Yet Recruiting to Recruiting
Study sites: 0 to 1
Start date changed from estimate of Sep 30, 2023 to Nov 5, 2023
v6
NotableStart date: Jul 15, 2023 to Sep 30, 2023v5
NotableStart date: Jun 1, 2023 to Jul 15, 2023v4
NotableStart date: Mar 1, 2023 to Jun 1, 2023v3
MinorEligibility criteria expanded, about 36 words
Secondary endpoints revised (4)
Study description shortened, about 14 words
v2
MinorStudy First Submitted
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Beads vs Vac trial is a multi-centre randomized controlled trial of 312 participants with a severe open tibia fracture requiring multiple irrigation and debridement surgeries. Eligible participants will be randomized to receive either an antibiotic bead pouch or negative pressure wound therapy (NPWT) for their temporary open fracture wound management. Outcomes will be assessed at 6 weeks, 3 months, and 6 months post-surgery. The primary outcome will be a composite outcome to evaluate clinical status six months after randomization. Components of the composite outcome will be hierarchically assessed in the following order: 1) all-cause mortality, 2) injury-related amputation of the lower extremity, 3) unplanned reoperation to manage wound complications, infection, or delayed fracture healing, and 4) clinical fracture healing as assessed using the Functional IndeX for Trauma (FIX-IT) instrument. The secondary outcomes will independently assess the four components of the primary outcome. This is a Phase III trial.